JP2024546145A5 - - Google Patents
Info
- Publication number
- JP2024546145A5 JP2024546145A5 JP2024535789A JP2024535789A JP2024546145A5 JP 2024546145 A5 JP2024546145 A5 JP 2024546145A5 JP 2024535789 A JP2024535789 A JP 2024535789A JP 2024535789 A JP2024535789 A JP 2024535789A JP 2024546145 A5 JP2024546145 A5 JP 2024546145A5
- Authority
- JP
- Japan
- Prior art keywords
- cell population
- activator
- activators
- activation
- mixed mononuclear
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163292843P | 2021-12-22 | 2021-12-22 | |
| US63/292,843 | 2021-12-22 | ||
| PCT/US2022/053815 WO2023122277A2 (en) | 2021-12-22 | 2022-12-22 | Rapid t-cell manufacturing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024546145A JP2024546145A (ja) | 2024-12-17 |
| JP2024546145A5 true JP2024546145A5 (https=) | 2026-01-06 |
Family
ID=86903666
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024535789A Pending JP2024546145A (ja) | 2021-12-22 | 2022-12-22 | 迅速ｔ－細胞製造 |
| JP2025536953A Pending JP2026501322A (ja) | 2021-12-22 | 2023-06-19 | 高速ｔ細胞製造 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025536953A Pending JP2026501322A (ja) | 2021-12-22 | 2023-06-19 | 高速ｔ細胞製造 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20250027042A1 (https=) |
| EP (2) | EP4453188A4 (https=) |
| JP (2) | JP2024546145A (https=) |
| KR (1) | KR20240123837A (https=) |
| CN (1) | CN119698465A (https=) |
| AR (2) | AR128077A1 (https=) |
| AU (1) | AU2022422123A1 (https=) |
| CA (1) | CA3239503A1 (https=) |
| CL (1) | CL2024001919A1 (https=) |
| CO (1) | CO2024008914A2 (https=) |
| IL (1) | IL313516A (https=) |
| MX (1) | MX2024007669A (https=) |
| UY (1) | UY40089A (https=) |
| WO (2) | WO2023122277A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024546145A (ja) * | 2021-12-22 | 2024-12-17 | クレ．エーアイ，インク． | 迅速ｔ－細胞製造 |
| WO2025083196A1 (en) | 2023-10-18 | 2025-04-24 | Tq Therapeutics Gmbh | A method of manufacturing a cellular therapy product and respective kits and devices |
| EP4725578A1 (en) | 2024-10-08 | 2026-04-15 | TQ Therapeutics GmbH | Column designs for affinity chromatography |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5244806A (en) * | 1985-08-26 | 1993-09-14 | Eli Lilly And Company | DNA encoding novel tissue plasminogen activator derivatives having kringles 1 and 2 deleted, vectors and host cells |
| CU24649B1 (es) * | 2016-03-19 | 2023-02-13 | Exuma Biotech Corp | Retrovirus recombinantes incompetentes de replicación para la transducción de linfocitos y expansión regulada de los mismos |
| GB201622044D0 (en) * | 2016-12-22 | 2017-02-08 | Ucl Business Plc | T cell-targeted T cells |
| CN113840911A (zh) * | 2018-09-02 | 2021-12-24 | 埃克苏马生物技术公司 | 用于在血液中或在富集pbmc中基因修饰淋巴细胞的方法和组合物 |
| JP2024546145A (ja) * | 2021-12-22 | 2024-12-17 | クレ．エーアイ，インク． | 迅速ｔ－細胞製造 |
-
2022
- 2022-12-22 JP JP2024535789A patent/JP2024546145A/ja active Pending
- 2022-12-22 IL IL313516A patent/IL313516A/en unknown
- 2022-12-22 AR ARP220103561A patent/AR128077A1/es unknown
- 2022-12-22 KR KR1020247024364A patent/KR20240123837A/ko active Pending
- 2022-12-22 US US18/714,302 patent/US20250027042A1/en active Pending
- 2022-12-22 CN CN202280085189.1A patent/CN119698465A/zh active Pending
- 2022-12-22 EP EP22912490.4A patent/EP4453188A4/en active Pending
- 2022-12-22 AU AU2022422123A patent/AU2022422123A1/en active Pending
- 2022-12-22 MX MX2024007669A patent/MX2024007669A/es unknown
- 2022-12-22 WO PCT/US2022/053815 patent/WO2023122277A2/en not_active Ceased
- 2022-12-22 UY UY0001040089A patent/UY40089A/es unknown
- 2022-12-22 CA CA3239503A patent/CA3239503A1/en active Pending
-
2023
- 2023-06-19 JP JP2025536953A patent/JP2026501322A/ja active Pending
- 2023-06-19 EP EP23908030.2A patent/EP4638711A1/en active Pending
- 2023-06-19 WO PCT/US2023/025663 patent/WO2024136920A1/en not_active Ceased
- 2023-08-02 AR ARP230102033A patent/AR130098A1/es unknown
-
2024
- 2024-06-21 CL CL2024001919A patent/CL2024001919A1/es unknown
- 2024-07-04 CO CONC2024/0008914A patent/CO2024008914A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024546145A5 (https=) | ||
| MacDonald et al. | Methods to manufacture regulatory T cells for cell therapy | |
| JP2023052777A5 (https=) | ||
| Levine et al. | Large-scale production of CD4+ T cells from HIV-1-infected donors after CD3/CD28 costimulation | |
| Zuliani et al. | Value of large scale expansion of tumor infiltrating lymphocytes in a compartmentalised gas-permeable bag: interests for adoptive immunotherapy | |
| US20080274091A1 (en) | Autologous T Cell Manufacturing Processes | |
| JP2018515108A (ja) | 準静的細胞培養 | |
| CN107922925A (zh) | 用于自然杀伤细胞扩增的方法 | |
| US20250354116A1 (en) | Method for enhancing production of genetically engineered autologous t cells | |
| JPH0339088A (ja) | 細胞捕獲及び回収のための装置及び方法 | |
| JP2008504821A (ja) | ベクター・パッケージング細胞系列 | |
| JP2024086827A5 (https=) | ||
| Song et al. | Scaling up and scaling out: Advances and challenges in manufacturing engineered T cell therapies | |
| JPH07504331A (ja) | 造血幹細胞の培養およびその遺伝子工学 | |
| WO2024136920A4 (en) | Rapid t-cell manufacturing | |
| JP2025066794A (ja) | 遺伝子改変自己ｔ細胞を製造するためのプロセス | |
| CN114317445B (zh) | 扩增t细胞的方法及其应用 | |
| JP2024535002A5 (https=) | ||
| AU2019206643A1 (en) | Cell reprogramming therapy | |
| CN108251376B (zh) | 人工抗原递呈细胞及其构建方法与在嵌合抗原受体t细胞扩增中的应用 | |
| CN111534489A (zh) | 一种基于3d打印的t淋巴细胞扩增方法 | |
| US12241086B2 (en) | Process for generating genetically engineered autologous T cells | |
| CN115916987A (zh) | 填充床生物反应器中的慢病毒载体制造方法 | |
| Kubik et al. | Manufacturing and clinical applications of non-CAR-T immune effector cells. | |
| Flint et al. | Accelerating vein-to-vein cell therapy workflows with new bioanalytical strategies |